Entrepix, a medical technology startup, launches Planatome Technology for creating precise, consistent incisions thereby improving clinical results.
Medical technology startup, Entrepix, just announced the launch of their Planatome Technology, ushering in a new era for the surgical scalpel. The company applies nano-polishing technology used in microchip manufacturing to surgical instruments.
The Planatome blade technology transforms the standard scalpel (originally patented in 1915) by creating what they call a “nano-perfected cutting surface.” Using a radically modern patented process based on that used to create a finished surface for computer chips, the Planatome scalpel eliminates grind defects found on standard scalpels thereby providing a smooth, precise, and consistent cutting surface that results in less tissue trauma.
A Planatome incision, they say, heals faster with the chance of fewer infections, strengthens the wound itself for less visible scarring, and reduces the chance of wound-related pain and nerve damage.
“Our atomically smooth surgical blades are unlike all other scalpels on the market, with inherent benefits to the patient that are innately intuitive and can be life-changing,” says Tim Tobin, chief executive officer of Entrepix Medical, in the release. “By employing a proven technology from the semiconductor industry, then adapting and perfecting it for use on surgical instruments, we provide surgeons an extraordinary version of their current preferred devices, dramatically transforming healing expectations through next-level performance. Research shows significant benefits when using a Planatome blade compared to a standard scalpel.”
According to the company, studies have shown a 90% vs. 10% wound closure rate for the Planatome scalpel vs. the traditional scalpel, respectively, attributing better healing results to the cleaner incision lines. In terms of nerves, those cut with a Planatome blade vs. scalpel had 25% vs. 9% recovery at 5 weeks post-op, with the Planatome incised nerves 92% recovered at 12 weeks. Further research showed a reduction in pain markers with the Planatome blade.
“Independent market research has shown that patients and surgeons alike are universally most concerned by the risks associated with post operative complications,” noted Bill Fender, president & COO of Entrepix Medical. “A Planatome blade is the only surgical instrument of its kind that provides the atomic level precision and consistency required to minimize these potential complications. With three additional patents pending, the benefits of Planatome Technology will capture the scalpel and extend to a host of additional surgical instruments.”